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Background: The Hopkins Verbal Learning Test (HVLT) has been validated for detecting dementia in
English-speaking populations. However, no studies have examined the Chinese version of the HVLT scale, and
appropriate cut-off scores for dementia in the Chinese population remain unclear.
Methods: 631 subjects aged 60 and over were recruited at a memory clinic at Dongzhimen Hospital in Beijing. Of
these, 249 were classified as exhibiting normal cognition (NC), 134 were diagnosed with mild cognitive impairment
(MCI), 97 were diagnosed with Alzheimer’s disease (AD), 14 met the diagnosis for vascular dementia (VaD), and 50
were diagnosed with other types of dementia, including mixed dementia. The discriminative capacity of the HVLT
total learning score, recognition score and total score were calculated to determine their sensitivity and specificity
for detecting MCI, AD and other dementias, and various cut-off scores.
Results: HVLT scores were affected by age, education and sex. The HVLT total learning score exhibited an optimal
balance between sensitivity and specificity using a cut-off score of 15.5 for distinguishing AD and other types of
dementia from NC using the ROC curve, with sensitivity of 94.7% for distinguishing AD and all types of dementia,
and specificity of 92.5% for detecting AD and 93.4% for detecting all types of dementias. We stratified the AD and
MCI groups by age, and calculated the validity in each age group. In the 50–64 years age group, when the cutoff
score was 18.5, the sensitivity of 0.955 and specificity of 0.921 were obtained for discriminating the NC and AD
groups, and in the 65–80 years group, and optimal sensitivity and specificity values (0.948 and 0.925, respectively)
were obtained with a cutoff score of 14.5.
When the cutoff score was 21.5 in HVLT total recall, an optimal balance was obtained between sensitivity and
specificity (69.1% and 70.7%, respectively) in distinguishing MCI from NC.
Conclusion: A cut-off score of 15.5 in the HVLT total learning score led to high discriminative capacity between the
dementia and NC groups. This suggests that the HVLT total learning score can provide a useful tool for
discriminating dementia, but not MCI, from NC in clinical and epidemiological practice.
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The increasing prevalence of dementia [1] is a major
health problem among older adults [2]. A recent study
reported that 5-9% of the Chinese population aged 65
years and over suffer from Alzheimer’s disease (AD) and
1-3% suffer from vascular dementia (VaD), with a total of
6 million patients with dementia in China at present [3].
With a rapidly ageing population in China, this preva-
lence rate is predicted to rise by more than 300% between
2001 and 2040 [4]. However, awareness, diagnosis and
treatment of dementia remain relatively low in China.
More than 48.8% of Chinese people regard dementia as a
normal part of the ageing process, only 23.3% of patients
with dementia seek medical advice, and 6.8% of patients
are treated, compared with 50% in Europe. One study
reported that the rate of misdiagnosis of dementia was
73.1%, and rates of treatment-seeking were 14.4%, 25.3%
and 33.6% for mild, moderate, and severe dementia, re-
spectively, between 1998 and 1999 [5]. Although the Na-
tional Institute of Neurologic, Communicative Disorders
and Stroke–Alzheimer Disease and Related Disorders
Association (NINCDS-ADRDA) criteria have high sensi-
tivity (up to 100%, with an average of 81% across studies),
but relatively low specificity (an average of 70% across
studies) for probable AD, based on class I–II studies with
post-mortem confirmation [6]. Diagnostic accuracy is
much lower in China, and most dementia is diagnosed in
neurology clinics, where formal neuropsychological tests
are lacking, because the diagnosis of dementia is expen-
sive and procedures are time-consuming. At present, the
diagnosis of dementia generally requires a medical his-
tory and neurological examination, laboratory blood
studies, mental status assessment and formal cognitive
tests, and computed tomography (CT) scans or magnetic
resonance imaging (MRI) of the brain [6]. As such, there
is a need to develop a useful test that can circumvent
aspects of this process and guide physicians to accurate
diagnosis. The Hopkins verbal learning test (HVLT) has
been developed in an attempt to fulfill to this need [7].
Previous studies have shown that HVLT total learning
score exhibits sensitivity and specificity of 87% and 98%,
respectively, for discriminating patients with dementia
from healthy controls [8], with an optimal discriminative
capacity between mild cognitive impairment (MCI) and
subjects with normal cognition (NC) [9]. However, all of
these previous studies were performed in English-
speaking countries, and no studies have examined the
HVLT in the Chinese population. As such, the current
study sought to establish the optimal cut-off score for
discriminating NC, MCI and AD subjects in a Chinese
population, and to evaluate the sensitivity and specificity
for discriminating these three groups. In addition, we
sought to determine whether HVLT scores are affected
by social and demographic factors.Methods
Subjects
A total of 631 subjects aged between 50 and 85 years
were recruited for this study between January 2011 and
September 2011 at a memory clinic at Dongzhimen
Hospital in Beijing, China.
All participants underwent a routine clinical assess-
ment, including detailed history, mental state exam-
ination, neurological examination, laboratory results
(i.e. thyroid function, folic acid levels, vitamin B12,
and routine blood tests, among others)and neuroi-
maging. Subjects were also assessed for the presence
of other psychiatric disease that could influence cog-
nition, including depressive disorder. Every participant
underwent a complete neuropsychological assessment that
mainly included the Instrumental Activities of Daily Living
(IADL) [10] scale, the Hachinski Ischemia scale (HIS) [11],
the Hamilton Depression Scale (HAMD) [12], the Adult
Memory and Information Processing Battery (AMIPB)
story recall [13], and the Clinical Dementia Rating (CDR)
[14] score.
The allocation of patients to different groups was
mainly based on results of the mental state examination,
neuropsychological assessment, laboratory results and
neuroimaging. The diagnosis algorithm is shown in
Figure 1.
Normal control subjects were identified according to
the Mayo research study criteria [15]: (1) no active
neurological or psychiatric disease, (2) no psychotropic
medication, (3) the subjects may have medical disorders
but neither they nor their treatment compromises cogni-
tive function, the Mini Mental Status Examination
(MMSE) [16,17] score >26 point (middle school),
MMSE >22(primary school), MMSE >19 (Illiteracy), and a
Clinical Dementia Rating (CDR) score of 0 [14].
The following criteria were used to define aMCI [18]:
(1) memory complaints usually corroborated by an in-
formant; (2) objective memory impairment (for age),
Clinical Dementia Rating (CDR) score of 0.5, memory
item score of 0.5; (3) normal general cognitive function,
as determined by a clinician's judgment based on a
structured interview with patients (a Mini-mental State
Examination [MMSE] score of 24 to 30 for education)
(cut-off scores: >19 for illiteracy, >22 for primary school,
>26 for middle school and above) [16,17]; (4) no or min-
imal impairment in activities of daily living, as deter-
mined by a clinical interview with the patient and
informant (an Instrumental Activities of Daily Living
[IADL] score of <16) [10]; and (5) not sufficiently
impaired, cognitively and functionally, to meet the
NINCDS-ADRDA criteria for AD [19], as judged by an
experienced AD research clinician. In addition, patients
exhibited a score of ≤12 of the Hamilton Depression
Scale (HAMD for 17 items) [12], ≤4 on the Hachinski
Figure 1 Diagnostic algorithm for Alzheimer’s disease, amnestic MCI, and normal cognition. Note: AD = Alzheimer’s disease; aMCI =
amnestic mild cognitive impairment; CDR = clinical dementia rating scale; MMSE = Mini-mental State Examination; NC = normal cognition; IADL =
Instrumental Activities of Daily Living; Hachinski Ischemia scale HAMD=Hamilton Depression Scale; EADC = Working Group of the European
Consortium on Alzheimer's Disease.
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temporal atrophy (MTA) or hippocampal volume atro-
phy on the MRI scan [20]. All subjects had sufficient
visual and auditory ability to complete the neuropsycho-
logical tests.
MCI exclusion criteria: (1) meeting criteria of dementia;
(2) any major psychiatric disorder (e.g., DSM-IV-defined
psychosis, major depression, bipolar disorder, or alcohol or
substance abuse); (3) other neurological diseases including
Parkinson's disease, or other neuropathy as verified by a
formal clinical examination.
The diagnosis of dementia was based on the Diagnos-
tic and Statistical Manual of Mental disorders, fourth
edition [21],and the diagnosis of AD was based on the
National Institute of Neurological Communicative Dis-
ease and Stroke (NINCDS) and Alzheimer's Disease and
Related Disorders Association (ADRDA) criteria [19] for
probable AD. Diagnosis of AD was based on clinical
and neuropsychological assessments (Mini-mental State
Examination: MMSE cutoff scores: ≤19 for illiteracy,
≤22 for primary school, ≤26 for middle school and
above.); (2) two or multiple domains cognitive impair-
ment; (3) Continued aggravation of memory and othercognitive functions; (4) absence of conscious distur-
bance; (5) impaired abilities of daily living, (IADL score
≥16); (6) without cerebrovascular disease, score of ≤4
on HIS; (7) and medial temporal atrophy (MTA) or
hippocampus volume atrophy on the MRI scan; (8) Ex-
clusion of other disease that may cause cognitive
impairment.
AD exclusion criteria: (1) onset of unexpected apo-
plexy; (2) focal nervous system signs in the early stages
of disease, for example, incomplete paralysis, anesthesia,
dysfunctional visual field, and dystaxia ;(3) epileptic at-
tack or gait disturbance in the early stages of disease; (4)
any major psychiatric disorder (e.g., DSM-IV-defined
psychosis, major depression, bipolar disorder, or alcohol
or substance abuse); HAMD>12 (17 items).
For each subject, the HVLT was conducted by five
examiners according to authors’ instructions [7]. The
test included 12 words and the subject was asked to read
aloud and freely recall immediately. This procedure was
repeated three times, and total learning scores were cal-
culated with the three free recall trails (range: 0–36). In
addition, the three free recall trials were followed by a
recognition trial consisting of 24 words, including 12
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target words; and six ‘other’ categories of unrelated
words. Subjects then performed yes/no recognition. Rec-
ognition was scored by subtracting the number of false
positive responses from the number of true positive
responses during the recognition trial. HVLT total score
was calculated by adding total learning and recognition
scores.
Five examiners were asked to administer the HVLT,
blinded to the subjects’ diagnosis. The HVLT test score
had no impact on diagnosis decisions for either the
patients with AD, dementia, aMCI or control subjects.
The study was undertaken in accordance with the
principles of the Declaration of Helsinki. The protocol
was approved by the Dongzhimen hospital institutional
Ethics Committee. The patients and their caregivers pro-
vided written informed consent.
Analysis
Statistical analyses were conducted using SPSS18.0 for
Windows. The four groups were compared using non-
parametric measures, and age, years of education,
gender-ratio and race were compared between groups
using Chi-squared tests.
The HVLT provides two basic summary scores. The
HVLT total learning score is defined as the total score
from the three free recall parts of the HVLT (=Trial1 +
Trial2 + Trial3). The HVLT recognition score is calcu-
lated by subtracting the number of false positive
responses from the number of true positive responses in
the recognition trial. The HVLT total score was calcu-
lated by the sum of the total learning and the recogni-
tion scores,and was used to examine the discriminative
ability of the test.
The ROC curves were calculated by plotting the sensi-
tivity against the 1-specificity for each score on the
HVLT total recall, recognition score and total score in
discriminating between cases of dementia versus NC, be-
tween cases of AD versus NC and between cases of
aMCI versus NC subjects. A multiple linear regression
analysis was used to determine the influence of age, sex
and education on HVLT score.
In addition, the positive predictive value (PPV) and
negative predictive value (NPV) were calculated based
on the prevalence in this sample.
Results
A total of 631 subjects were enrolled. Three patients did
not complete the neuropsychological test, 71 exhibited
depression, 14 exhibited vascular cognitive impairment
(VCI), 14 exhibited vascular dementia (VaD), 50 exhib-
ited mixed dementia and other types of dementia, while
the remaining 249 were classified as NC, 134 were diag-
nosed with aMCI, and 97 were diagnosed with AD. The‘all types of dementia’ group (n = 161) included the AD
only group (n = 97), the VaD only group (n = 14) and
the mixed dementia group (n = 50). The diagnostic algo-
rithm for AD and aMCI and NC is shown in Figure 1.
The demographic and neuropsychological characteris-
tics of the different diagnostic categories are shown in
Table 1. There were significant differences between the
four groups. Subjects in the all types of dementia group
and AD group were significantly older than those in the
aMCI group (P = 0.000 and P = 0.000 for all types of de-
mentia and AD groups, respectively), and had fewer
years of education (P = 0.000 and P = 0.000 for the all
types of dementia and AD groups, respectively). In
addition, the aMCI group was significantly older than
the NC group (P = 0.000) and had fewer years of educa-
tion (P = 0.000).
The results revealed a significant difference between
the four groups with respect to MMSE scores, HVLT
total learning, HVLT recognition and HVLT total score
(P = 0.000, P = 0.000). The all types of dementia group
and AD group exhibited lower performance than the
aMCI group in total learning (P = 0.000, P = 0.000, re-
spectively), recognition (P = 0.000, P = 0.000, respect-
ively), total score (P = 0.000, P = 0.000, respectively) and
MMSE score (P = 0.000, P = 0.000, respectively) (see
also Table 1), and aMCI patients exhibited poorer per-
formance than the NC group regarding to all of the
above tests. The ratio of HVLT total score / MMSE
score exhibited a significant difference between the NC,
MCI, AD and all types of dementia groups (P = 0.000).
However, we found no significant differences between
the AD group and the all types of dementia group in the
HVLT total/MMSE ratio (P = 0.56). (P = 0.56).
There were no significant differences between the all
types of dementia group and the AD group regarding
age, sex, education, race, MMSE, and the HVLT total
learning score, total scores (P > 0.05).
The ROC curves were produced by plotting the sensi-
tivity against the 1-specificity for each score on the
HVLT total learning, recognition score and total score
in discriminating between cases of dementia versus NC,
between AD cases versus NC and between cases of
aMCI versus the NC group.
Impact of demographic factors on HVLT
A multiple linear regression analysis was conducted with
the HVLT total learning score as the dependent variable
and age and years of education as independent variables.
The results revealed significant effects (F = 54.607,
P = 0.000), accounting for 38.7% of HVLT total learning
scores, age (standardized coefficients = −0.253,
P = 0.000) and years of education (standardized coeffi-
cients = 0.273, P = 0.000) impacted on HVLT total
learning score.
Table 1 Demographic data and scores on neuropsychological tests
Diagnostic category
NC n=249 aMCI n=134 AD n=97 All type of dementia n=161
Age 67.08(8.33) 69.89(8.23) ** 71.08(8.43) ** 71.0893(8.43) **
Education 12.89(3.30) 11.32(3.84) ** 10.62(4.49) ** 10.55(4.39) **
Sex(female/male) 158/91 76/58 54/43 81/80
Race(Han/others) 240/9 126/7 93/3 153/7
MMSE 28.41(1.50) 26.98(2.04) ** 15.69(5.91) **△△ 16.28(6.06)**△△
HVLT
Trail 1 5.91(1.90) 4.48(1.69) ** 1.46(1.81) **△△ 1.57(1.76) **△△
Trail 2 8.54(2.05) 6.48(2.15) ** 2.28(2.27) **△△ 2.41(2.22) **△△
Trail 3 9.63(1.91) 7.21(2.65) ** 2.55(2.59) **△△ 2.71(2.45) **△△
Total learning 23.76(5.66) 18.04(5.93) ** 6.09(6.23) **△△ 6.37(5.91) **△△
Recognition 11.29(1.23) 10.32(2.18) ** 3.42(5.38) **△△ 3.95(5.52) **△△
HVLT total score 35.34(5.59) 28.49(6.67) ** 9.65(10.54) **△△ 10.54(10.19)**△△
HVLT total score/MMSE ratio 1.23(0.23) 1.05(0.26) 0.46(0.60) 0.50(0.56)
HAMD 3.78(3.30) 3.84(3.12) ** 2.42(2.12) **△△ 2.78(2.47) **△△
Notes: Data are presented as mean (standard deviation); NC = normal cognition; aMCI = amnestic mild cognitive impairment; AD = Alzheimer’s disease; MMSE = Mini-mental
state examination; HVLT = Hopkins verbal learning test; HAMD = Hamilton Depression scale;**p < 0.001 compared to NC; p < 0.001 compared to aMCI.
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Figure 2 shows the sensitivity and specificity for distin-
guishing the aMCI group from the NC group, for total
learning, recognition score and total HVLT, with differ-
ent cut-off scores. The area under the curve (AUC) was
0.774 for the HVLT total learning score, and 0.79 for the
HVLT total score. When the cutoff score was 21.5 in the
HVLT total learning, an optimal balance was obtained
between the sensitivity and specificity (69.1% and 70.7%,
respectively) in distinguishing aMCI and NC. With a cut-Figure 2 ROC curve of the HVLT discriminate amnestic mild cognitive
learning test, ROC = Receiver operating characteristic.off value of 32.5, the HVLT total score exhibited sensitiv-
ity and specificity of 68.7% and 70.7%, respectively.
The AUC was 0.666 for the HVLT recognition score,
0.589 for sensitivity, and 0.699 for specificity, when the
cutoff score was 11.5. The sensitivity and specificity for
HVLT recognition score were relatively low, indicating
that this was not an ideal tool for discriminating aMCI
from NC in our sample.
Because the HVLT total learning score was associated
with age, the cut-off score was calculated in different ageimpairment from normal cognition. Notes: HVLT = Hopkins verbal
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score was 23.5, optimal sensitivity (0.700) and specificity
(0.718) values were achieved in discriminating the NC
and aMCI groups. In addition, optimal sensitivity (0.776)
and specificity (0.562) values were obtained when the
cutoff score was 18.5 in the 65–80 year-old patients.
NC versus AD and all types of dementia
Optimum sensitivity and specificity of HVLT total learn-
ing score, HVLT recognition score and HVLT total score
for discriminating AD and all types of dementia from
NC were determined by the ROC curve analysis using
the most appropriate cut-off scores. The total AUC for
total learning score was 0.976 for discriminating AD,
and 0.982 for detecting all types of dementia. The total
AUC for the HVLT total score was 0.982 for discrimin-
ating AD, and 0.986 for detecting all types of dementia.
The total learning score exhibited optimal sensitivity and
specificity using a cut-off score of 15.5 for detecting NC
and AD and all types of dementia, with similar sensitiv-
ity for detecting AD and all types of dementia (94.7% for
both), and specificity of 92.5% for AD, and 93.4% for all
types of dementia. The HVLT total score exhibited bet-
ter overall discrimination of AD and all types of demen-
tia patients, using a cut-off score of 25.5, with 93.5%
specificity and 95.5% sensitivity for detecting AD, and
with 93.9% specificity and 96.0% sensitivity when the op-
timal cutoff score was 26.5 for detecting all types of
dementia.
In the 50–64 years age-group optimal values for sensi-
tivity (0.955) and specificity (0.921) were obtained for
discriminating the NC and AD groups when the cutoff
score was 18.5. Optimal values for sensitivity (0.948) and
specificity (0.925) were obtained with a cutoff score ofTable 2 Sensitivity and specificity of HVLT total learning scor
of dementia (PPV) and probabilities of no dementia (NPV) at
All type of dementia
HVLT Cut-off Sensitivity Specificity
<10.50 1.000 0.762 0
<11.50 0.996 0.781 0
<12.50 0.996 0.841 0
<13.50 0.967 0.854 0
<14.50 0.963 0.901 0
<15.50* 0.947 0.934 0
<16.50 0.919 0.947 0
<17.50 0.898 0.947 0
<18.50 0.858 0.974 0
<19.50 0.801 0.974 0
<20.50 0.756 0.980 0
<21.50 0.691 0.980 0
* indicate the cutoff with optical sensitivity and specificity.14.5 in the 65–80 years age-group for discriminating the
NC and AD groups.
The HVLT recognition scores for discriminating all
types of dementia and AD were also calculated. The
AUC was 0.96 for detecting AD, and 0.935 for detecting
all types of dementia.
The sensitivity, specificity, PPV and NPV of HVLT
total learning cut-off scores for different prevalence rates
of all types of dementia are shown in Table 2. In our
sample, the prevalence of all types of dementia was
39.19%, and when the cut-off score the HVLT total
learning score was 15.5, the PPV was 0.90, and NPV was
0.95. The PPV was impacted by the baseline prevalence,
with PPV increasing when prevalence increased.
Discussion
In the current study, we calculated the optimal cut-off
scores in our sample for detecting aMCI, AD, and all
types of dementia from NC controls. The results
revealed that the HVLT alone works equally well for dis-
tinguishing both AD and all types of dementia. We
investigated the optimal discriminative capacity of the
HVLT for distinguishing between NC controls and cases
with AD and all types of dementia. The results revealed
that the optimal balance between sensitivity and specifi-
city for detecting the NC from AD and all types of de-
mentia with the HVLT total learning score was obtained
with a cutoff score of 15.5. Other studies have reported
similar results, achieving much higher sensitivity and
specificity (0.96 and 0.80, respectively) with a cut-off
score of 18–19 resulting in sensitivity and specificity of
0.96 and 0.80, respectively [22]. The difference in cut-off
scores may be because of a difference between the sam-
ple in the present experiment and this previous study. Ines to discriminate all types of dementia and probabilities
different baseline rates
PPV/NPV at different base rate
5% 10% 15% 20%
.18/1.00 0.32/1.00 0.43/1.00 0.51/1.00
.19/0.99 0.34/0.99 0.45/0.99 0.53/0.99
.25/099 0.41/0.99 0.53/0.99 0.61/0.99
.26/0.96 0.42/0.96 0.54/0.96 0.62/0.96
.34/0.96 0.52/0.96 0.63/0.96 0.71/0.96
.43/0.95 0.61/0.95 0.72/0.95 0.78/0.95
.48/0.92 0.66/0.92 0.75/0.92 0.81/0.92
.47/0.90 0.65/0.90 0.75/0.90 0.81/0.90
.63/0.87 0.79/0.87 0.85/0.87 0.89/0.87
.62/0.83 0.77/0.83 0.84/0.83 0.89/0.83
.67/0.80 0.81/0.80 0.87/0.80 0.90/0.80
.65/0.76 0.79/0.76 0.86/0.76 0.90/0.76
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erate to severe cognitive impairment, and the mean
MMSE score was 16.28. In contrast, a previous study
included mild dementia subjects and mild cognitive im-
pairment, reporting a mean MMSE score of 21.8 [22].
As a screening test for dementia, sensitivity is likely to
be more important than specificity for detecting a
greater number of patients in the general population.
However, among dementia patients, specificity may be
more important than sensitivity when examining sub-
jects with severe dementia. In the current sample, sensi-
tivity of 85.8% and specificity of 91.0% were obtained
when the cut-off score was 18.5 for discriminating mild
AD (CDR = 1). When the cut-off score was 15.5 for dis-
criminating moderate AD (CDR = 2), sensitivity of
94.7% and specificity of 100% were obtained. These
results suggest that the HVLT has higher specificity for
discriminating AD from NC.
However, the HVLT revealed a relatively low discrim-
ination capacity for detecting aMCI from NC. In the
current study, when the optimal cut-off score was 21.5
for detecting aMCI from NC, we obtained low sensitivity
(69.1%) and specificity (70.7%) respectively. These values
are lower than those in another study showing that the
HVLT has specificity of 95% and sensitivity of 79% in
detecting MCI when the optimal cutoff was 25.5 [9].
This discrepancy may be related to the small sample size
of the previous study, which only recruited 21 aMCI
patients and 98 normal controls, substantially smaller
than the sample in the present study.. Another possible
explanation for the difference between the current find-
ings and previous reports is that global cognition, mea-
sured by MMSE, was substantially lower in the current
study compared to previous reports in the aMCI group.
The lower HVLT total learning scores in aMCI patients
in the current study may have led to lower optimal cut-
off scores.
In our study sample, multiple linear regression analysis
revealed that demographic variables (i.e., sex, age and
education) affected HVLT total recall. Other studies
have reported a positive relationship between HVLT
scores and years of education [23]. Higher levels of edu-
cation were associated with a higher HVLT total learn-
ing score. Cognitive reserve may have also affected the
current results. Since patients with a higher educational
level exhibit greater cognitive reserves, more pathology
may be required before memory begins to be affected
24]. In addition, age had an inverse impact on the HVLT
total learning score. When controlling for education and
sex, older subjects exhibited lower HVLT total scores.
On the contrary, a number of studies have reported
no relationship between HVLT total learning scores
and age [8,9,23]. The HVLT total learning score was
also influenced by sex, with females exhibiting lowersores than males when controlling for age and educa-
tion. This may because of the different physiological
characteristics of gender, or as a result of environmental
and social factors [25].
The MMSE is widely used to assess global cognition in
clinical settings for many years, and the MMSE is
recommended as a screening tool for early dementia [6].
A previous study reported that when the cut-off score
for the MMSE was 24.5, the sensitivity and specificity
were 0.89 and 0.91,respectively, for detecting dementia
in subjects with higher educated [26]. However, a num-
ber of studies have reported that the MMSE has lower
discriminating capacity than HVLT for detecting demen-
tia [8,9,23]. In addition, a ceiling effect has been reported
for the MMSE, with 30% of controls achieving perfect
scores [8]. The MMSE score is also affected by age and
education [26]. Taken together, these findings indicate
that the HVLT may be more suitable for screening
purposes.
The PPV and NPV of HVLT total learning score in the
current study were relatively high. This finding suggests
that subjects with negative results on the HVLT total
learning score may not require further neuropsycho-
logical evaluations.Conclusion
The current results revealed that the HVLT total learn-
ing score and total score can discriminate well between
cases of dementia and NC controls, suggesting that it is
a useful tool in clinical and epidemiological practice.
When the cut-off score of the HVLT total learning score
was 15.5, it was capable of a high level of discrimination
between dementia and normal controls. When the
HVLT was used to discriminate aMCI patients from NC
controls, discrimination capacity was relatively low.
When an optimal cut-off score of 21.5 was used for
detecting aMCI from NC, sensitivity of 69.1% and speci-
ficity of 70.7% were obtained. Hence, further study may
be needed to detect the use of HVLT for aMCI.
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